Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Evidence for D276G and L364I Bcr-Abl mutations in Ph+ leukaemic cells obtained from patients resistant to Imatinib.

× No keyword cloud information.

4 in total

Review 1. Anticipating clinical resistance to target-directed agents : the BCR-ABL paradigm.

Authors: Mohammad Azam; George Q Daley
Journal: Mol Diagn Ther Date: 2006 Impact factor: 4.074

2. Determining the rise in BCR-ABL RNA that optimally predicts a kinase domain mutation in patients with chronic myeloid leukemia on imatinib.

Authors: Richard D Press; Stephanie G Willis; Jennifer Laudadio; Michael J Mauro; Michael W N Deininger
Journal: Blood Date: 2009-07-22 Impact factor: 22.113

3. De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways.

Authors: Vera Magistroni; Mario Mauri; Deborah D'Aliberti; Caterina Mezzatesta; Ilaria Crespiatico; Miriam Nava; Diletta Fontana; Nitesh Sharma; Wendy Parker; Andreas Schreiber; David Yeung; Alessandra Pirola; Sara Readelli; Luca Massimino; Paul Wang; Praveen Khandelwal; Stefania Citterio; Michela Viltadi; Silvia Bombelli; Roberta Rigolio; Roberto Perego; Jacqueline Boultwood; Alessandro Morotti; Giuseppe Saglio; Dong-Wook Kim; Susan Branford; Carlo Gambacorti-Passerini; Rocco Piazza
Journal: Haematologica Date: 2019-02-28 Impact factor: 9.941

4. Detection of ABL1 kinase domain mutations in therapy-naïve BCR-ABL1-positive acute lymphoblastic leukemia.

Authors: Constance Baer; Manja Meggendorfer; Claudia Haferlach; Wolfgang Kern; Torsten Haferlach
Journal: Haematologica Date: 2022-02-01 Impact factor: 9.941

4 in total